CAREMILE_2.png)
RT-PCR
Detection Kits
Molecular Diagnosis
WHO currently recommends a single approach to clinical diagnostic testing for disease confirmation which is the detection of unique sequences of SARS-CoV-2 RNA by nucleic acid amplification testing (NAAT), such as real-time reverse-transcription polymerase chain reaction (rRT-PCR).
[Letter of Priority Distributorship Authorization]
SolGent
DiaPlexQ™
Novel Coronavirus (2019-nCoV) Detection Kit
FDA-EUA Approved
-
DiaPlexQ™ Novel Coronavirus(2019-nCov) Detection Kit is a CE-IVD assay reagent.
-
It is designed to detect the nucleic acid of novel coronavirus contained in total RNA extracted from blood suspected patients.
-
The kit is based on Real-Time RT PCR method.
-
Additional reagent purchase is not needed, as 5 components are equipped required for PCR reaction.
-
SolGent's OneStep qRT-PCR method performs RT reaction and Real-time PCR amplification reaction sequentially in one tube without separate experiment for RT reaction.
-
Detection time, cost and sensitivity were improved compared to conventional PCR diagnosis.
AMSBIO
A+CheQ
COVID-19 High Speed RT-qPCR
KFDA-EUA Approved
-
Fastest COVID-19 Detection Kit (Within 1 hour from specimen extraction to diagnosis results)
-
100% Accuracy diagnosis (Sensitivity: 100% / Specificity: 100)
-
High compatibility with various Real-time PCR equipments
-
Establishment of the largest production facility in Korea (Minimum 2,000 kits can be produced per day)
-
Cat. No. : RR001
-
100 Tests/Kit
-
Storage : − 24°C ~ − 18°C
-
Sample to Result : 52 min [Prep 23 min + qPCR 29 min] 3-plex Multiplex
-
Clinical Sensitivity : 100%
-
Clinical Specificity : 100%